Quite the detailed letter, isn't it! This just adds one more reason why I simply don't like Biogen and their practices when it comes to promoting drugs to MS patients.
It's no secret that Biogen's market predictions for Tysabri are well below what they had hoped. So it doesn't surprise me that they have used the comcasts in question to try and improve their market share. I guess it doesn't bother them one bit to falsely the facts as long as it brings in more revenue!!
I'm glad that the FDA has taken this action against them. Thanks for providing us the link so we can all see how this company operates.